Back
Trevi Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
TRVI
Trevi Therapeutics
Last Price:
$6.47
Seasonality Move:
40.55%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Trevi Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.47 | Buy |
20-day SMA: | 6.54 | Sell |
50-day SMA: | 6.29 | Buy |
200-day SMA: | 4.13 | Buy |
8-day EMA: | 6.46 | Buy |
20-day EMA: | 6.44 | Buy |
50-day EMA: | 6.06 | Buy |
200-day EMA: | 4.53 | Buy |
Trevi Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 52.86 | Buy |
Chaikin Money Flow: | 579796 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.14 - 6.74) | Buy |
Bollinger Bands (100): | (4.08 - 6.36) | Buy |
Trevi Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.49 while TRVI 8-day simple moving average is 6.47, which is a Buy signal.
-
The stock price of TRVI is 6.49 while Trevi Therapeutics 20-day SMA is 6.54, which makes it a Sell.
-
Trevi Therapeutics 50-day simple moving average is 6.29 while TRVI share price is 6.49, making it a Buy technically.
-
TRVI stock price is 6.49 and Trevi Therapeutics 200-day simple moving average is 4.13, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $6.49. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
660.3M
Price in USD:
6.49
Share Volume:
773.1K
Trevi Therapeutics 52-Week Range
52-Week High:
7.39
52-Week Low:
2.30
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 6.49 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.49 while TRVI 8-day exponential moving average is 6.46, which is a Buy signal.
-
The stock price of TRVI is 6.49 while Trevi Therapeutics 20-day EMA is 6.44, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 6.06 while TRVI share price is 6.49, making it a Buy technically.
-
TRVI stock price is 6.49 and Trevi Therapeutics 200-day simple moving average is 4.53, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 52.86, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (6.14 - 6.74), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (4.08 - 6.36), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.